CALQUENCE

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: 0bbb4172a806efff
Drug Approval Canada Name: CALQUENCE
Product Name: CALQUENCE
Status: Marketed
Status Date: 2019-10-02
Original Market Date: 2019-10-02
Din: 02491788
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EL02 ACALABRUTINIB
Atc Name: l 01 el 02
Aig Number: 0161750001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

ACALABRUTINIB

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0bbb4172a806efff

Type

Standard